# Hikma Pharmaceuticals LLC – FDA Inspection, Sep 5, 2019

Source: https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-llc/6277d74f-baf0-459a-967a-660b10579d63
Source feed: FDA_Inspections

> FDA inspection 1101407 of Hikma Pharmaceuticals LLC, September 05, 2019. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101407
- Company Name: Hikma Pharmaceuticals LLC
- Inspection Date: 2019-09-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 981353 - 2016-07-27](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-llc/193e7e0e-6255-409e-9810-4a1543d27a9d)
- [FDA Inspection 935111 - 2015-06-25](https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-llc/2436b6f5-092b-4dc1-9987-642fa6215ad7)
- FDA Inspection 782232 - 2012-04-12
- FDA Inspection 645014 - 2010-02-04

## Related Officers

- [Investigator](https://www.keypedia.com/people/jose-a-lopez-rubet/1d1f18e7-bb35-442f-829e-e21b0c081bfa)
- [Issuing Officer](https://www.keypedia.com/people/libia-m-lugo/893802aa-76a6-4fb5-ab71-eaee099e4f67)

Company: https://www.keypedia.com/companies/hikma-pharmaceuticals-llc/85cbc2fc-4814-4b0b-aaff-a6d0e60238d3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c